help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lefebvre, H.
Right arrow Articles by Kuhn, J.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lefebvre, H.
Right arrow Articles by Kuhn, J.-M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Cushing's Syndrome
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 7 3035-3042
Copyright © 2003 by The Endocrine Society


CLINICAL CASE SEMINAR

Intraadrenal Adrenocorticotropin Production in a Case of Bilateral Macronodular Adrenal Hyperplasia Causing Cushing’s Syndrome

Herve Lefebvre, Celine Duparc, Nicolas Chartrel, Sylvie Jegou, Anne Pellerin, Annie Laquerriere, Richard Ivell, Hubert Vaudry and Jean-Marc Kuhn

European Institute for Peptide Research, Department of Endocrinology and Metabolic Diseases, INSERM, U-413 (H.L., J.M.K.), and Department of Pathology, Centre Hospitalo-Universitaire of Rouen (A.P., A.L.), 76031 Rouen, France; Laboratory of Cellular and Molecular Neuroendocrinology, INSERM, U-413, Unité affilieé au Centre National de la Recherche Scientifique, University of Rouen, (H.L., C.D., N.C., S.J., H.V., J.M.K.), 76821 Mont Saint Aignan, France; and Institute for Hormone and Fertility Research, University of Hambourg (R.I.), D-22529 Hambourg, Germany

Address all correspondence and requests for reprints to: Dr. H. Lefebvre, European Institute for Peptide Research, Service d’Endocrinologie et Maladies Métaboliques, Hôpital de Boisguillaume, Centre Hospitalo-Universitaire de Rouen, 76031 Rouen Ceex, France. E-mail: herve.lefebvre{at}chu-rouen.fr.

Adrenochromaffin cells have been shown to physiologically synthesize and secrete ACTH. We have thus hypothesized that excessive intraadrenal ACTH production may be involved in the pathogenesis of primary adrenal Cushing’s syndrome. In this report we describe a case of Cushing’s syndrome due to bilateral adrenocortical macronodular hyperplasia associated with suppression of plasma ACTH levels. HPLC analysis of adrenal tissue extracts revealed the presence of a peptide coeluting with bioactive ACTH. Immunohistochemical studies showed that ACTH immunoreactivity was detectable in a subpopulation of steroidogenic cells, but not in chromaffin cells. ACTH-positive cells were also labeled by antibodies against relaxin-like factor, a marker of Leydig cells. The presence of ACTH in the hyperplastic tissue resulted from local expression of the gene encoding the ACTH precursor proopiomelanocortin. Finally, hyperplasia fragments, contrary to normal adrenal cortex explants, appeared to release in vitro measurable amounts of ACTH. In conclusion, this observation shows that Cushing’s syndromes associated with suppressed plasma ACTH levels may be dependent upon ACTH produced within adrenocortical tissue. The term ACTH-independent used to designate primary adrenal Cushing’s syndrome may therefore be inappropriate in some cases of bilateral macronodular adrenal hyperplasia with hypercortisolism and undetectable plasma ACTH levels.

This work was supported by the Conseil Régional de Haute-Normandie, Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23; INSERM, U-413; and the Centre Hospitalo-Universitaire de Rouen.

Abbreviations: 5-HT4, 5-Hydroxytryptamine4; Pit1, pituitary-specific transcription factor-1; POMC, proopiomelanocortin; Prop1, prophet of pituitary-specific transcription factor-1; Ptx1, pituitary homeobox factor-1; RLF, relaxin-like factor.




This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
R. Ivell and R. Anand-Ivell
Biology of insulin-like factor 3 in human reproduction
Hum. Reprod. Update, July 1, 2009; 15(4): 463 - 476.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
D. Cartier, S. Jegou, F. Parmentier, I. Lihrmann, E. Louiset, J.-M. Kuhn, C. Bastard, P.-F. Plouin, M. Godin, H. Vaudry, et al.
Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas
Eur. J. Endocrinol., December 1, 2005; 153(6): 939 - 947.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society